PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

SANUWAVE Health, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from SANUWAVE Health, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 97% of Healthcare companies in United States.
  • Cash Cushion Ratio: Debt, after subtracting cash, equals 24% of its market value (net debt). Lower than 87% of Healthcare companies in United States.
  • Shareholder Slice Ratio: Share count rose 487% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 86% of Healthcare companies in United States.

Where $100 of sales goes

$89Operating costs$14Interest$27Net profit

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

$7

For every $100 of sales, $7 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $3 tied up three years earlier.

Less money tied up than 83% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 1/3

Sales grew in 3 of the last 3 years; profit grew in 1 of 3.

Steadier than 69% of Healthcare companies in United States.

Growth Efficiency Ratio

$81

Sales grew 163% in 3 years; of every extra $100 of sales, $81 became extra profit.

Higher than 78% of Healthcare companies in United States.

Asset Productivity Ratio

+163% / +88%

In 3 years sales changed by +163% while total assets changed by +88%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

0.7×

Debt due within a year is covered 0.7 times by its yearly operating cash.

Higher than 71% of Healthcare companies in United States.

Cash Cushion Ratio

−24%

Debt, after subtracting cash, equals 24% of its market value (net debt).

Lower than 87% of Healthcare companies in United States.

Tangible Assets Ratio

72%

Of every $100 the company owns, $72 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 60% of Healthcare companies in United States.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than 97% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+487%

Share count rose 487% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 86% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

SANUWAVE Health, Inc. owes $0.92 for every $1 it owns. SANUWAVE Health, Inc. returned to profit in the year to Dec 2025, after a loss the year before.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

22.1

Investors pay $22.1 for every $1 of SANUWAVE Health, Inc.'s yearly profit, lower than 59% of Healthcare companies in United States.

P/B ratio

16.36

The share price is 16.36 times SANUWAVE Health, Inc.'s book value per share, higher than 91% of Healthcare companies in United States.

Market cap

$46 M

The total market value of all of SANUWAVE Health, Inc.'s shares at today's price (share price × number of shares), smaller than 75% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$3 M

What SANUWAVE Health, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$0.32

Net worth divided by the number of shares. The share price of $5.30 is 16.4 times this, which is the P/B above.

Owes vs Owns

0.92×

SANUWAVE Health, Inc. owes $0.92 for every $1 it owns (high), higher than 84% of Healthcare companies in United States.

Dividend yield

None

SANUWAVE Health, Inc. does not currently pay a dividend.

Revenue growth

+35%

Revenue rose 35% in the year to Dec 2025, and grew 38% a year on average over 3 years.

Profit growth

Back to profit

SANUWAVE Health, Inc. returned to profit in the year to Dec 2025, after a loss the year before.

Profit margin

26.8%

SANUWAVE Health, Inc. keeps $27 of every $100 of revenue as net profit.

Cash quality

0.3×

Cash from SANUWAVE Health, Inc.'s business was 0.3× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.

Interest cover

0.8×

SANUWAVE Health, Inc.'s operating profit covered its interest costs 0.8 times in the year to Dec 2025.

Cash vs debt

Net debt

SANUWAVE Health, Inc. had $11 M more debt than cash (net debt) at Dec 2025.

Questions

What is SANUWAVE Health, Inc.'s P/E ratio?

Investors pay $22.1 for every $1 of SANUWAVE Health, Inc.'s yearly profit, lower than 59% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For SANUWAVE Health, Inc.: $46 M ÷ $3 M (30 Jun 2026) = 16.4.

How much does SANUWAVE Health, Inc. owe compared with what it owns?

SANUWAVE Health, Inc. owes $0.92 for every $1 it owns (high), higher than 84% of Healthcare companies in United States.

Does SANUWAVE Health, Inc. pay a dividend?

No. SANUWAVE Health, Inc. does not currently pay a dividend.

Is SANUWAVE Health, Inc.'s revenue growing?

Revenue rose 35% in the year to Dec 2025, and grew 38% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.